+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics

Examining the pathogenesis of breast cancer using a novel agent-based model of mammary ductal epithelium dynamics

Plos one 8(5): E64091

The study of the pathogenesis of breast cancer is challenged by the long time-course of the disease process and the multi-factorial nature of generating oncogenic insults. The characterization of the longitudinal pathogenesis of malignant transformation from baseline normal breast duct epithelial dynamics may provide vital insight into the cascading systems failure that leads to breast cancer. To this end, extensive information on the baseline behavior of normal mammary epithelium and breast cancer oncogenesis was integrated into a computational model termed the Ductal Epithelium Agent-Based Model (DEABM). The DEABM is composed of computational agents that behave according to rules established from published cellular and molecular mechanisms concerning breast duct epithelial dynamics and oncogenesis. The DEABM implements DNA damage and repair, cell division, genetic inheritance and simulates the local tissue environment with hormone excretion and receptor signaling. Unrepaired DNA damage impacts the integrity of the genome within individual cells, including a set of eight representative oncogenes and tumor suppressors previously implicated in breast cancer, with subsequent consequences on successive generations of cells. The DEABM reproduced cellular population dynamics seen during the menstrual cycle and pregnancy, and demonstrated the oncogenic effect of known genetic factors associated with breast cancer, namely TP53 and Myc, in simulations spanning ∼40 years of simulated time. Simulations comparing normal to BRCA1-mutant breast tissue demonstrated rates of invasive cancer development similar to published epidemiologic data with respect to both cumulative incidence over time and estrogen-receptor status. Investigation of the modeling of ERα-positive (ER+) tumorigenesis led to a novel hypothesis implicating the transcription factor and tumor suppressor RUNX3. These data suggest that the DEABM can serve as a potentially valuable framework to augment the traditional investigatory workflow for future hypothesis generation and testing of the mechanisms of breast cancer oncogenesis.

Please choose payment method:

(PDF emailed within 1 workday: $29.90)

Accession: 053111488

Download citation: RISBibTeXText

PMID: 23704974

Related references

Examining the Relationship between Pre-Malignant Breast Lesions, Carcinogenesis and Tumor Evolution in the Mammary Epithelium Using an Agent-Based Model. Plos one 11(3): E0152298, 2016

Initiation of metastatic breast carcinoma by targeting of the ductal epithelium with adenovirus-cre: a novel transgenic mouse model of breast cancer. Journal of Visualized Experiments 2014(85):, 2014

Genetic abnormalities in mammary ductal intraepithelial neoplasia-flat type (clinging ductal carcinoma in situ): A simulator of normal mammary epithelium. Cancer 88(9): 2072-2081, 2000

Prophylactic and therapeutic treatment of the ductal epithelium for a mammary gland for cancer. Official Gazette of the United States Patent & Trademark Office Patents 1253(2), 2001

Prophylactic and therapeutic treatment of the ductal epithelium of a mammary gland for cancer. Official Gazette of the United States Patent & Trademark Office Patents 1277(1), 2003

Integrating evolutionary game theory into an agent-based model of ductal carcinoma in situ: Role of gap junctions in cancer progression. Computer Methods and Programs in Biomedicine 136: 107-117, 2016

The value of examining 19 carbon steroids in urine of women with ductal breast cancer. Cancer Detection & Prevention 3(1), 1980

Physiological COX-2 expression in breast epithelium associates with COX-2 levels in ductal carcinoma in situ and invasive breast cancer in young women. American Journal of Pathology 184(4): 1219-1229, 2014

Risk factors for breast cancer death and subsequent invasive breast cancer after a primary ductal carcinoma in situ of the breast A population-based case-control study. Breast Cancer Research & Treatment 46(1): 44, 1997

Lattice-based model of ductal carcinoma in situ suggests rules for breast cancer progression to an invasive state. Plos Computational Biology 10(12): E1003997, 2014

Conjugated linoleic acid acts directly on the mammary epithelium and indirectly through the mammary stroma, to prevent breast cancer. Journal of the American College of Nutrition 19(5): 677, 2000

Expression of Her2/neu, steroid receptors (ER and PR), Ki67 and p53 in invasive mammary ductal carcinoma associated with ductal carcinoma In Situ (DCIS) Versus invasive breast cancer alone. Anticancer Research 25(3a): 1719-1723, 2005

Aurora kinase-A overexpression in mouse mammary epithelium induces mammary adenocarcinomas harboring genetic alterations shared with human breast cancer. Carcinogenesis 37(12): 1180-1189, 2016

Localisation of COX-2 protein is different in breast ductal carcinoma and adjacent non-tumour ductal epithelium. Clinical and Translational Oncology 7(6): 239-243, 2005